Search results
Showing 46 to 47 of 47 results for bortezomib multiple myeloma
This guidance has been updated and replaced by NICE technology appraisal guidance 427.
NICE leads the way in approving breakthrough treatment for multiple myeloma
People in England will become the first in the world to receive belantamab mafodotin for this indication following our recommendation and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approval earlier this year.